Aktana

Youssef's guiding principle for driving transformation

Today’s guest rose through the ranks of retail giants L’Oreal and Levi Strauss before landing his current role shaping data science strategy at one of the world’s leading biotech companies. In this episode, we’re joined by Youssef Idelcaid, the senior director of data science for Commercial, Medical and Government Affairs at Genentech. Listen as he shares what surprised him most about his transition from retail to life sciences, his best advice for getting started with&nbsp;AI, and how he decides when to stay in-house and when to outsource data science projects. And don’t miss “Youssef in Context,” where we discuss his greatest career inspiration, a new title for your must-read list, and who’s invited to Youssef’s ultimate bolognese dinner.&nbsp;

Youssef Idelcaid

Senior Director of Data Science for Commercial, Medical and Government Affairs at Genentech

Retail-native Youssef Idelcaid, who currently leads data science strategy for commercial, medical and government affairs at Genentech, offers his unique, cross-industry perspective on cultivating impactful data science programs and driving transformation from the inside-out. 




Shaping Your Data Science Strategy with Genentech's Youssef Idelcaid

Shaping Your Data Science Strategy with Youssef Idelcaid of Genentech 

Aktana | Contextual Intelligence Podcast

Contextual Intelligence

Product 

Resources

Contextual Intelligence can be defined as taking what you learn and making it work from one situation to another. That’s what we’ll aim to do in this series. Hosted by Clay Hausmann, the Chief Revenue Officer of Aktana, we’ll have lively discussions with very smart and interesting people, and hopefully, share some learnings that you can apply to your own business situation.

Build Once, Deploy Many: Laying the Foundation for Omnichannel AI at Scale 

Introduction to Health Recommender Systems (HRS) 

The Perfect Data Myth: Why You're More Ready for Omnichannel AI Than You Think 

Democratizing AI: Bridging the Intelligence Divide in Commercial Life Sciences 